National Malaria Control Programme, Federal Ministry of Health, PO Box 1204 Khartoum, Sudan.
Malar J. 2011 May 15;10:128. doi: 10.1186/1475-2875-10-128.
The epidemiology of fevers and their management in areas of low malaria transmission in Africa is not well understood. The characteristics of fever, its treatment and association with infection prevalence from a national household sample survey in the northern states of Sudan, an area that represents historically low parasite prevalence, are examined in this study.
In October-November 2009, a cluster sample cross-sectional household malaria indicator survey was undertaken in the 15 northern states of the Sudan. Data on household assets and individual level information on age, sex, whether the individual had a fever in the last 14 days and on the day of survey, actions taken to treat the fever including diagnostic services and drugs used and their sources were collected. Consenting household members were asked to provide a finger-prick blood sample and examined for malaria parasitaemia using a rapid diagnostic test (RDT). All proportions and odds ratios were weighted and adjusted for clustering.
Of 26,471 respondents 19% (n = 5,299) reported a history of fever within the last two weeks prior to the survey and 8% had fever on the day of the survey. Only 39% (n = 2,035) of individuals with fever in last two weeks took any action, of which 43% (n = 875) were treated with anti-malarials. About 44% (n = 382) of malaria treatments were done using the nationally recommended first-line therapy artesunate+sulphadoxine-pryrimethamine (AS+SP) and 13% (n = 122) with non-recommended chloroquine or SP. Importantly 33.9% (n = 296) of all malaria treatments included artemether monotherapy, which is internationally banned for the treatment of uncomplicated malaria. About 53% of fevers had some form of parasitological diagnosis before treatment. On the day of survey, 21,988 individuals provided a finger-prick blood sample and only 1.8% were found positive for Plasmodium falciparum. Infection prevalence was higher among individuals who had fever in the last two weeks (OR = 3.4; 95%CI = 2.6 - 4.4, p < 0.001) or reported fever on the day of survey (OR = 6.2; 95%CI = 4.4 - 8.7, p < 0.001) compared to those without a history of fever.
Across the northern states of the Sudan, the period prevalence of fever is low. The proportion of fevers that are likely to be malaria is very low. Consequently, parasitological diagnosis of all fevers before treatment is an appropriate strategy for malaria case-management. Improved regulation and supervision of health workers is required to increase the use of diagnostics and remove the practice of prescribing artemisinin monotherapy.
在疟疾传播水平较低的非洲地区,发热的流行病学特征及其处理方法尚不清楚。本研究旨在探讨苏丹北部各州(历史上寄生虫感染率较低的地区)全国家庭抽样调查中发热的特征、治疗方法及其与感染率的关系。
2009 年 10 月至 11 月,在苏丹北部 15 个州开展了疟疾指示性家庭横断面抽样调查。收集了家庭资产和个人层面的信息,包括年龄、性别、过去 14 天内是否发热、调查当天是否发热、发热时采取的治疗措施(包括诊断服务和使用的药物以及来源)。同意的家庭成员被要求提供指血样,并使用快速诊断检测(RDT)进行疟疾寄生虫检测。所有比例和比值比均经过加权处理,并根据聚类进行了调整。
在 26471 名受访者中,19%(n=5299)报告在调查前两周内有发热史,8%(n=1529)在调查当天发热。仅有 39%(n=2035)的发热患者采取了任何治疗措施,其中 43%(n=875)接受了抗疟药物治疗。大约 44%(n=382)的疟疾治疗采用了国家推荐的一线治疗药物青蒿琥酯+磺胺多辛-乙胺嘧啶(AS+SP),13%(n=122)采用了非推荐药物氯喹或磺胺多辛。重要的是,33.9%(n=296)的所有疟疾治疗均包含青蒿素单药疗法,而国际上已禁止将青蒿素单药疗法用于治疗无并发症的疟疾。在治疗前,约 53%的发热患者进行了某种形式的寄生虫学诊断。在调查当天,21988 人提供了指血样,仅发现 1.8%的人感染恶性疟原虫。与无发热史者相比,在过去两周内有发热史(OR=3.4;95%CI=2.6-4.4,p<0.001)或报告当天发热(OR=6.2;95%CI=4.4-8.7,p<0.001)的个体中,发热的感染率更高。
在苏丹北部各州,发热的流行率较低。发热中可能为疟疾的比例非常低。因此,在治疗前对所有发热患者进行寄生虫学诊断是疟疾病例管理的一项适当策略。需要加强对卫生工作者的监管和规范,以增加诊断服务的使用,并消除开具青蒿素单药疗法的做法。